• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC NEUROMODULATION COVEREDGE X 32; STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED FOR PAIN RELIEF

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC NEUROMODULATION COVEREDGE X 32; STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED FOR PAIN RELIEF Back to Search Results
Model Number SC-8352-70
Medical Device Problem Codes Unexpected Therapeutic Results (1631); Migration (4003)
Health Effect - Clinical Code Inadequate Pain Relief (2388)
Date of Event 04/19/2022
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that the patient was experiencing inadequate stimulation of the targeted pain area; bilateral back and legs.Multiple reprogramming attempts were made, however, only the left inner thigh was able to obtain coverage.An x-ray was performed which confirmed that the lead had migrated.The patient underwent a lead revision procedure where the lead was explanted and replaced.The patient is expected to fully recover.
 
Event or Problem Description
It was reported that the patient was experiencing inadequate stimulation of the targeted pain area; bilateral back and legs.Multiple reprogramming attempts were made, however, only the left inner thigh was able to obtain coverage.An x-ray was performed which confirmed that the lead had migrated.The patient underwent a lead revision procedure where the lead was explanted and replaced.The patient is expected to fully recover.
 
Additional Manufacturer Narrative
The returned lead was analyzed; passed all tests performed and exhibited normal device characteristics.Engineers have concluded that the reported event of lead migration, resulting in inadequate stimulation is a known inherent risk with implanting a pulse generator as part of a system to deliver spinal cord stimulation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COVEREDGE X 32
Common Device Name
STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED FOR PAIN RELIEF
Manufacturer (Section D)
BOSTON SCIENTIFIC NEUROMODULATION
25155 rye canyon loop
valencia CA 91355
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
road 698, lot no. 12
dorado PR 00646 -260
*   00646-2602
Manufacturer Contact
talar tahmasian
25155 rye canyon loop
valencia, CA 91355
6619494863
MDR Report Key14432186
Report Number3006630150-2022-02315
Device Sequence Number5628760
Product Code LGW
UDI-Device Identifier08714729832690
UDI-Public08714729832690
Combination Product (Y/N)N
Initial Reporter CountryCA
PMA/510(K) Number
P030017
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Device Explanted Year2022
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 07/12/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date04/23/2020
Device Model NumberSC-8352-70
Device Catalogue NumberSC-8352-70
Device Lot Number7015475
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 04/19/2022
Supplement Date Received by Manufacturer06/13/2022
Initial Report FDA Received Date05/18/2022
Supplement Report FDA Received Date07/12/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured04/24/2018
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-